{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:56:30Z","timestamp":1786982190881,"version":"build-2736575974"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,3,6]],"date-time":"2025-03-06T00:00:00Z","timestamp":1741219200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,3,6]],"date-time":"2025-03-06T00:00:00Z","timestamp":1741219200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"the Startup Fund for scientific research, Fujian Medical University","award":["2020QH1228"],"award-info":[{"award-number":["2020QH1228"]}]},{"DOI":"10.13039\/100014717","name":"National Outstanding Youth Science Fund Project of National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82172821"],"award-info":[{"award-number":["82172821"]}],"id":[{"id":"10.13039\/100014717","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014717","name":"National Outstanding Youth Science Fund Project of National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82372753"],"award-info":[{"award-number":["82372753"]}],"id":[{"id":"10.13039\/100014717","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Tianjin Municipal Science and Technology Project","award":["19JCYBJC27400"],"award-info":[{"award-number":["19JCYBJC27400"]}]},{"name":"Tianjin Municipal Science and Technology Project","award":["21JCZDJC00360"],"award-info":[{"award-number":["21JCZDJC00360"]}]},{"DOI":"10.13039\/100017167","name":"International Centre for Theoretical Sciences","doi-asserted-by":"publisher","award":["2021ZD033"],"award-info":[{"award-number":["2021ZD033"]}],"id":[{"id":"10.13039\/100017167","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Tianjin Key Medical Discipline(Specialty) Construction Project","award":["TJYXZDXK-009A"],"award-info":[{"award-number":["TJYXZDXK-009A"]}]},{"name":"Tianjin Key Medical Discipline(Specialty) Construction Project","award":["TJYXZDXK-058B"],"award-info":[{"award-number":["TJYXZDXK-058B"]}]},{"name":"Tianjin Health Research Project","award":["TJWJ2022XK024"],"award-info":[{"award-number":["TJWJ2022XK024"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"DOI":"10.1007\/s12020-025-04205-y","type":"journal-article","created":{"date-parts":[[2025,3,6]],"date-time":"2025-03-06T08:23:45Z","timestamp":1741249425000},"page":"798-819","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Consensus nonnegative matrix factorization reveals metastatic gene expression program and identifies E74-like ETS transcription factor 3 confers to the lymph nodes metastasis in papillary thyroid cancer"],"prefix":"10.1007","volume":"88","author":[{"given":"Mei","family":"Tao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuping","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yimeng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianhui","family":"Ruan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jialong","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junya","family":"Ning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangqian","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,6]]},"reference":[{"key":"4205_CR1","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.jncc.2024.01.006","volume":"4","author":"B Han","year":"2024","unstructured":"B. Han, R. Zeng, H. Zeng et al. Cancer incidence and mortality in China, 2022. J. Natl Cancer Cent. 4, 47\u201353 (2024)","journal-title":"J. Natl Cancer Cent."},{"key":"4205_CR2","doi-asserted-by":"publisher","first-page":"383","DOI":"10.3390\/cancers12020383","volume":"12","author":"L Fugazzola","year":"2020","unstructured":"L. Fugazzola, M. Muzza, G. Pogliaghi et al. Intratumoral Genetic Heterogeneity in Papillary Thyroid Cancer: Occurrence and Clinical Significance. Cancers 12, 383 (2020)","journal-title":"Cancers"},{"key":"4205_CR3","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/S2213-8587(22)00035-3","volume":"10","author":"M Pizzato","year":"2022","unstructured":"M. Pizzato, M. Li, J. Vignat et al. The epidemiological landscape of thyroid cancer worldwide: GLOBOCAN estimates for incidence and mortality rates in 2020. Lancet Diabetes Endocrinol. 10, 264\u2013272 (2022)","journal-title":"Lancet Diabetes Endocrinol."},{"key":"4205_CR4","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1210\/er.2019-00007","volume":"40","author":"ME Cabanillas","year":"2019","unstructured":"M.E. Cabanillas, M. Ryder, C. Jimenez, Targeted therapy for advanced thyroid cancer: kinase inhibitors and beyond. Endocr. Rev. 40, 1573\u20131604 (2019)","journal-title":"Endocr. Rev."},{"key":"4205_CR5","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/j.cell.2017.01.018","volume":"168","author":"N Mcgranahan","year":"2017","unstructured":"N. Mcgranahan, C. Swanton, Clonal heterogeneity and tumor evolution: past, present, and the future. Cell 168, 613\u2013628 (2017)","journal-title":"Cell"},{"key":"4205_CR6","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1038\/nature12627","volume":"501","author":"PL Bedard","year":"2013","unstructured":"P.L. Bedard, A.R. Hansen, M.J. Ratain et al. Tumour heterogeneity in the clinic. Nature 501, 355\u2013364 (2013)","journal-title":"Nature"},{"key":"4205_CR7","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1089\/thy.2018.0339","volume":"29","author":"C Colombo","year":"2019","unstructured":"C. Colombo, M. Muzza, M.C. Proverbio et al. Impact of mutation density and heterogeneity on papillary thyroid cancer clinical features and remission probability. Thyroid 29, 237\u2013251 (2019)","journal-title":"Thyroid"},{"key":"4205_CR8","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1089\/thy.2019.0052","volume":"30","author":"T Masoodi","year":"2020","unstructured":"T. Masoodi, A.K. Siraj, S. Siraj et al. Whole-exome sequencing of matched primary and metastatic papillary thyroid cancer. Thyroid 30, 42\u201356 (2020)","journal-title":"Thyroid"},{"key":"4205_CR9","doi-asserted-by":"publisher","first-page":"e169653","DOI":"10.1172\/JCI169653","volume":"133","author":"L Lu","year":"2023","unstructured":"L. Lu, J.R. Wang, Y.C. Henderson et al. Anaplastic transformation in thyroid cancer revealed by single-cell transcriptomics. J. Clin. Invest. 133, e169653 (2023)","journal-title":"J. Clin. Invest."},{"key":"4205_CR10","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1530\/ERC-14-0351","volume":"22","author":"S Le Pennec","year":"2015","unstructured":"S. Le Pennec, T. Konopka, D. Gacquer et al. Intratumor heterogeneity and clonal evolution in an aggressive papillary thyroid cancer and matched metastases. Endocr. Relat. Cancer 22, 205\u2013216 (2015)","journal-title":"Endocr. Relat. Cancer"},{"key":"4205_CR11","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1007\/s12022-019-09593-2","volume":"30","author":"M Gawin","year":"2019","unstructured":"M. Gawin, A. Kurczyk, E. Stobiecka et al. Molecular heterogeneity of papillary thyroid cancer: comparison of primary tumors and synchronous metastases in regional lymph nodes by mass spectrometry imaging. Endocr. Pathol. 30, 250\u2013261 (2019)","journal-title":"Endocr. Pathol."},{"key":"4205_CR12","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1038\/s41422-020-0374-x","volume":"30","author":"Y-P Chen","year":"2020","unstructured":"Y.-P. Chen, J.-H. Yin, W.-F. Li et al. Single-cell transcriptomics reveals regulators underlying immune cell diversity and immune subtypes associated with prognosis in nasopharyngeal carcinoma. Cell Res. 30, 1024\u20131042 (2020)","journal-title":"Cell Res."},{"key":"4205_CR13","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1016\/j.cell.2019.06.024","volume":"178","author":"C Neftel","year":"2019","unstructured":"C. Neftel, J. Laffy, M.G. Filbin et al. An Integrative Model of Cellular States, Plasticity, and Genetics for Glioblastoma. Cell 178, 835\u2013849.e21 (2019)","journal-title":"Cell"},{"key":"4205_CR14","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1038\/s41586-023-06130-4","volume":"618","author":"A Gavish","year":"2023","unstructured":"A. Gavish, M. Tyler, A.C. Greenwald et al. Hallmarks of transcriptional intratumour heterogeneity across a thousand tumours. Nature 618, 598\u2013606 (2023)","journal-title":"Nature"},{"key":"4205_CR15","doi-asserted-by":"publisher","first-page":"e2401712","DOI":"10.1002\/advs.202401712","volume":"11","author":"W Zhang","year":"2024","unstructured":"W. Zhang, X. Ruan, Y. Huang et al. SETMAR Facilitates the Differentiation of Thyroid Cancer by Regulating SMARCA2-Mediated Chromatin Remodeling. Adv. Sci. 11, e2401712 (2024)","journal-title":"Adv. Sci."},{"key":"4205_CR16","doi-asserted-by":"publisher","first-page":"2265","DOI":"10.1038\/s41418-023-01217-x","volume":"30","author":"J Ning","year":"2023","unstructured":"J. Ning, X. Hou, J. Hao et al. METTL3 inhibition induced by M2 macrophage-derived extracellular vesicles drives anti-PD-1 therapy resistance via M6A-CD70-mediated immune suppression in thyroid cancer. Cell Death Differ. 30, 2265\u20132279 (2023)","journal-title":"Cell Death Differ."},{"key":"4205_CR17","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.7150\/thno.66142","volume":"12","author":"W Zhang","year":"2022","unstructured":"W. Zhang, X. Ruan, Y. Li et al. KDM1A promotes thyroid cancer progression and maintains stemness through the Wnt\/\u03b2-catenin signaling pathway. Theranostics 12, 1500\u20131517 (2022)","journal-title":"Theranostics"},{"key":"4205_CR18","doi-asserted-by":"publisher","first-page":"e43803","DOI":"10.7554\/eLife.43803","volume":"8","author":"D Kotliar","year":"2019","unstructured":"D. Kotliar, A. Veres, M.A. Nagy et al. Identifying gene expression programs of cell-type identity and cellular activity with single-cell RNA-Seq. Elife 8, e43803 (2019)","journal-title":"Elife"},{"key":"4205_CR19","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1038\/s41592-019-0619-0","volume":"16","author":"I Korsunsky","year":"2019","unstructured":"I. Korsunsky, N. Millard, J. Fan et al. Fast, sensitive and accurate integration of single-cell data with Harmony. Nat. Methods 16, 1289\u20131296 (2019)","journal-title":"Nat. Methods"},{"key":"4205_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-26343-3","volume":"12","author":"W Pu","year":"2021","unstructured":"W. Pu, X. Shi, P. Yu et al. Single-cell transcriptomic analysis of the tumor ecosystems underlying initiation and progression of papillary thyroid carcinoma. Nat. Commun. 12, 6058 (2021)","journal-title":"Nat. Commun."},{"key":"4205_CR21","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1016\/j.cell.2014.09.050","volume":"159","author":"Cancer Genome Atlas Research Network","year":"2014","unstructured":"Cancer Genome Atlas Research Network, Integrated genomic characterization of papillary thyroid carcinoma. Cell 159, 676\u2013690 (2014)","journal-title":"Cell"},{"key":"4205_CR22","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"A. Subramanian, P. Tamayo, V.K. Mootha et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl Acad. Sci. USA 102, 15545\u201315550 (2005)","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"4205_CR23","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/nbt.2859","volume":"32","author":"C Trapnell","year":"2014","unstructured":"C. Trapnell, D. Cacchiarelli, J. Grimsby et al. The dynamics and regulators of cell fate decisions are revealed by pseudotemporal ordering of single cells. Nat. Biotechnol. 32, 381\u2013386 (2014)","journal-title":"Nat. Biotechnol."},{"key":"4205_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-50194-3","volume":"15","author":"Z Zeng","year":"2024","unstructured":"Z. Zeng, Y. Ma, L. Hu et al. OmicVerse: a framework for bridging and deepening insights across bulk and single-cell sequencing. Nat. Commun. 15, 5983 (2024)","journal-title":"Nat. Commun."},{"key":"4205_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-21246-9","volume":"12","author":"S Jin","year":"2021","unstructured":"S. Jin, C.F. Guerrero-Juarez, L. Zhang et al. Inference and analysis of cell-cell communication using CellChat. Nat. Commun. 12, 1088 (2021)","journal-title":"Nat. Commun."},{"key":"4205_CR26","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2014-15-3-r47","volume":"15","author":"P Geeleher","year":"2014","unstructured":"P. Geeleher, N.J. Cox, R.S. Huang, Clinical drug response can be predicted using baseline gene expression levels and in vitro drug sensitivity in cell lines. Genome Biol. 15, R47 (2014)","journal-title":"Genome Biol."},{"key":"4205_CR27","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1038\/s41421-022-00434-x","volume":"8","author":"J Yang","year":"2022","unstructured":"J. Yang, X. Zhou, J. Dong et al. Single-cell profiling reveals molecular basis of malignant phenotypes and tumor microenvironments in small bowel adenocarcinomas. Cell Discov. 8, 92 (2022)","journal-title":"Cell Discov."},{"key":"4205_CR28","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-021-01001-x","volume":"13","author":"C Fustero-Torre","year":"2021","unstructured":"C. Fustero-Torre, M.J. Jim\u00e9nez-Santos, S. Garc\u00eda-Mart\u00edn et al. Beyondcell: targeting cancer therapeutic heterogeneity in single-cell RNA-seq data. Genome Med. 13, 187 (2021)","journal-title":"Genome Med."},{"key":"4205_CR29","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1172\/JCI85271","volume":"126","author":"I Landa","year":"2016","unstructured":"I. Landa, T. Ibrahimpasic, L. Boucai et al. Genomic and transcriptomic hallmarks of poorly differentiated and anaplastic thyroid cancers. J. Clin. Investigation 126, 1052\u20131066 (2016)","journal-title":"J. Clin. Investigation"},{"key":"4205_CR30","doi-asserted-by":"publisher","first-page":"eadg7125","DOI":"10.1126\/sciadv.adg7125","volume":"9","author":"P Yu","year":"2023","unstructured":"P. Yu, N. Qu, R. Zhu et al. TERT accelerates BRAF mutant-induced thyroid cancer dedifferentiation and progression by regulating ribosome biogenesis. Sci. Adv. 9, eadg7125 (2023)","journal-title":"Sci. Adv."},{"key":"4205_CR31","doi-asserted-by":"publisher","first-page":"682561","DOI":"10.3389\/fcell.2021.682561","volume":"9","author":"L Zhang","year":"2021","unstructured":"L. Zhang, D. Xiong, Q. Liu et al. Genome-Wide histone H3K27 acetylation profiling identified genes correlated with prognosis in papillary thyroid carcinoma. Front. Cell Dev. Biol. 9, 682561 (2021)","journal-title":"Front. Cell Dev. Biol."},{"key":"4205_CR32","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.1200\/JCO.2005.12.085","volume":"23","author":"JL Grem","year":"2005","unstructured":"J.L. Grem, G. Morrison, X.-D. Guo et al. Phase I and pharmacologic study of 17-(allylamino)-17-demethoxygeldanamycin in adult patients with solid tumors. J. Clin. Oncol. 23, 1885\u20131893 (2005)","journal-title":"J. Clin. Oncol."},{"key":"4205_CR33","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1089\/thy.2013.0057","volume":"23","author":"KB Kim","year":"2013","unstructured":"K.B. Kim, M.E. Cabanillas, A.J. Lazar et al. Clinical responses to vemurafenib in patients with metastatic papillary thyroid cancer harboring BRAF(V600E) mutation. Thyroid 23, 1277\u20131283 (2013)","journal-title":"Thyroid"},{"key":"4205_CR34","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/s41586-023-06054-z","volume":"618","author":"F Mart\u00ednez-Jim\u00e9nez","year":"2023","unstructured":"F. Mart\u00ednez-Jim\u00e9nez, A. Movasati, S.R. Brunner et al. Pan-cancer whole-genome comparison of primary and metastatic solid tumours. Nature 618, 333\u2013341 (2023)","journal-title":"Nature"},{"key":"4205_CR35","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1016\/j.ajhg.2019.09.026","volume":"105","author":"T Masoodi","year":"2019","unstructured":"T. Masoodi, A.K. Siraj, S. Siraj et al. Evolution and impact of subclonal mutations in papillary thyroid cancer. Am. J. Hum. Genet. 105, 959\u2013973 (2019)","journal-title":"Am. J. Hum. Genet."},{"key":"4205_CR36","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1007\/s12020-019-02030-8","volume":"66","author":"H Shakib","year":"2019","unstructured":"H. Shakib, S. Rajabi, M.H. Dehghan et al. Epithelial-to-mesenchymal transition in thyroid cancer: a comprehensive review. Endocrine 66, 435\u2013455 (2019)","journal-title":"Endocrine"},{"key":"4205_CR37","doi-asserted-by":"publisher","first-page":"249","DOI":"10.7150\/thno.87306","volume":"14","author":"C F\u00e9brissy","year":"2024","unstructured":"C. F\u00e9brissy, M. Adlanmerini, C. P\u00e9queux et al. Reprogramming of endothelial gene expression by tamoxifen inhibits angiogenesis and ER\u03b1-negative tumor growth. Theranostics 14, 249\u2013264 (2024)","journal-title":"Theranostics"},{"key":"4205_CR38","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1007\/s00018-016-2347-2","volume":"74","author":"K Song","year":"2017","unstructured":"K. Song, H. Wu, H.N.A. Rahman et al. Endothelial epsins as regulators and potential therapeutic targets of tumor angiogenesis. Cell Mol. Life Sci. 74, 393\u2013398 (2017)","journal-title":"Cell Mol. Life Sci."},{"key":"4205_CR39","doi-asserted-by":"publisher","first-page":"5848","DOI":"10.3390\/ijms23105848","volume":"23","author":"G Manfioletti","year":"2022","unstructured":"G. Manfioletti, M. Fedele, Epithelial-Mesenchymal Transition (EMT) 2021. Int. J. Mol. Sci. 23, 5848 (2022)","journal-title":"Int. J. Mol. Sci."},{"key":"4205_CR40","doi-asserted-by":"publisher","first-page":"109385","DOI":"10.1016\/j.cellsig.2019.109385","volume":"63","author":"L Huang","year":"2019","unstructured":"L. Huang, C. Hu, H. Chao et al. Drug-resistant endothelial cells facilitate progression, EMT and chemoresistance in nasopharyngeal carcinoma via exosomes. Cell Signal. 63, 109385 (2019)","journal-title":"Cell Signal."},{"key":"4205_CR41","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-020-00776-9","volume":"12","author":"W Lin","year":"2020","unstructured":"W. Lin, P. Noel, E.H. Borazanci et al. Single-cell transcriptome analysis of tumor and stromal compartments of pancreatic ductal adenocarcinoma primary tumors and metastatic lesions. Genome Med. 12, 80 (2020)","journal-title":"Genome Med."},{"key":"4205_CR42","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1038\/35099076","volume":"2","author":"AD Sharrocks","year":"2001","unstructured":"A.D. Sharrocks, The ETS-domain transcription factor family. Nat. Rev. Mol. Cell Biol. 2, 827\u2013837 (2001)","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"4205_CR43","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-24695-3","volume":"8","author":"EB Wondimu","year":"2018","unstructured":"E.B. Wondimu, K.L. Culley, J. Quinn et al. Elf3 contributes to cartilage degradation in vivo in a surgical model of post-traumatic osteoarthritis. Sci. Rep. 8, 6438 (2018)","journal-title":"Sci. Rep."},{"key":"4205_CR44","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.ydbio.2013.12.028","volume":"386","author":"M B\u00f6ck","year":"2014","unstructured":"M. B\u00f6ck, J. Hinley, C. Schmitt et al. Identification of ELF3 as an early transcriptional regulator of human urothelium. Dev. Biol. 386, 321\u2013330 (2014)","journal-title":"Dev. Biol."},{"key":"4205_CR45","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.3390\/molecules23092191","volume":"23","author":"IY Luk","year":"2018","unstructured":"I.Y. Luk, C.M. Reehorst, J.M. Mariadason, ELF3, ELF5, EHF and SPDEF transcription factors in tissue homeostasis and cancer. Molecules 23, 2191 (2018)","journal-title":"Molecules"},{"key":"4205_CR46","first-page":"570","volume":"41","author":"H Chen","year":"2019","unstructured":"H. Chen, W. Chen, X. Zhang et al. E26 transformation (ETS)\u2011specific related transcription factor\u20113 (ELF3) orchestrates a positive feedback loop that constitutively activates the MAPK\/Erk pathway to drive thyroid cancer. Oncol. Rep. 41, 570\u2013578 (2019)","journal-title":"Oncol. Rep."},{"key":"4205_CR47","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/s12253-017-0324-1","volume":"25","author":"K Czirbesz","year":"2019","unstructured":"K. Czirbesz, E. Gorka, T. Balatoni et al. Efficacy of vemurafenib treatment in 43 metastatic melanoma patients with BRAF mutation. Single-Institute retrospective analysis, early real-life survival data. Pathol. Oncol. Res. 25, 45\u201350 (2019)","journal-title":"Pathol. Oncol. Res."},{"key":"4205_CR48","first-page":"5453","volume":"35","author":"SH Kim","year":"2015","unstructured":"S.H. Kim, J.G. Kang, C.S. Kim et al. 17-Allylamino-17-demethoxygeldanamycin and herbimycin A induce cell death by modulating \u03b2-Catenin and PI3K\/AKT signaling in FRO anaplastic thyroid carcinoma cells. Anticancer. Res. 35, 5453\u20135460 (2015)","journal-title":"Anticancer. Res."},{"key":"4205_CR49","doi-asserted-by":"publisher","first-page":"2982","DOI":"10.1210\/jc.2003-031767","volume":"89","author":"M Braga-Basaria","year":"2004","unstructured":"M. Braga-Basaria, E. Hardy, R. Gottfried et al. 17-Allylamino-17-demethoxygeldanamycin activity against thyroid cancer cell lines correlates with heat shock protein 90 levels. J. Clin. Endocrinol. Metab. 89, 2982\u20132988 (2004)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"4205_CR50","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1007\/s12094-019-02283-9","volume":"43","author":"C Wang","year":"2020","unstructured":"C. Wang, R. Zhang, J. Tan et al. Effect of mesoporous silica nanoparticles co\u2011loading with 17\u2011AAG and Torin2 on anaplastic thyroid carcinoma by targeting VEGFR2. Oncol. Rep. 43, 1491\u20131502 (2020)","journal-title":"Oncol. Rep."},{"key":"4205_CR51","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-022-04550-0","volume":"13","author":"L Hu","year":"2022","unstructured":"L. Hu, J. Zhang, M. Tian et al. Pharmacological inhibition of Ref-1 enhances the therapeutic sensitivity of papillary thyroid carcinoma to vemurafenib. Cell Death Dis. 13, 124 (2022)","journal-title":"Cell Death Dis."},{"key":"4205_CR52","doi-asserted-by":"publisher","first-page":"2192","DOI":"10.1158\/2159-8290.CD-23-0050","volume":"13","author":"HF Farin","year":"2023","unstructured":"H.F. Farin, M.H. Mosa, B. Ndreshkjana et al. Colorectal cancer organoid-stroma biobank allows subtype-specific assessment of individualized therapy responses. Cancer Discov. 13, 2192\u20132211 (2023)","journal-title":"Cancer Discov."}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-025-04205-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12020-025-04205-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-025-04205-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T12:03:33Z","timestamp":1749211413000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12020-025-04205-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,6]]},"references-count":52,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025,6]]}},"alternative-id":["4205"],"URL":"https:\/\/doi.org\/10.1007\/s12020-025-04205-y","relation":{},"ISSN":["1559-0100"],"issn-type":[{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,6]]},"assertion":[{"value":"10 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"This study was approved by the Medical Ethics Committee of Tianjin Medical University Cancer Institute & Hospital, National Clinical Research Center for Cancer (Approval number: 2023013).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}